Citation
Peginterferon alfa-2a, bictegravir–emtricitabine–tenofovir alafenamide, and venetoclax in adult T-cell leukemia/lymphoma. // Blood. – URL: https://www.sciencedirect.com/science/article/pii/S000649712611547X?dgcid=rss_sd_all
Peginterferon alfa-2a, bictegravir–emtricitabine–tenofovir alafenamide, and venetoclax in adult T-cell leukemia/lymphoma. Blood. https://www.sciencedirect.com/science/article/pii/S000649712611547X?dgcid=rss_sd_all
“Peginterferon alfa-2a, bictegravir–emtricitabine–tenofovir alafenamide, and venetoclax in adult T-cell leukemia/lymphoma.” Blood.
@article{article93383,
title = {Peginterferon alfa-2a, bictegravir–emtricitabine–tenofovir alafenamide, and venetoclax in adult T-cell leukemia/lymphoma},
journal = {Blood},
url = {https://www.sciencedirect.com/science/article/pii/S000649712611547X?dgcid=rss_sd_all}
}